معرفی
Elsa Arbajian is a Researcher at the Division of Clinical Genetics, Lund University, specializing in cancer genetics and molecular biology. She is affiliated with the Lund University Cancer Centre (LUCC) and the Research Group Lung Cancer.
- Research Focus: Genomics, epigenetics, and proteogenomics of breast/lung cancer and soft tissue tumors
- Key Tools: Deep sequencing, RNA sequencing, organoid modeling
Research Output Trends: Her work addresses molecular subtypes, therapeutic resistance mechanisms, and prognostic predictors in triple-negative breast cancer and non-small cell lung cancer, with recent studies on DNA methylation landscapes and RET inhibition strategies.
Scientific Awards:
- Crafoord Foundation Grant (2025-2026) as Principal Investigator for advanced lung cancer genomics
- Crafoord Foundation Grant (2023-2024) for organoid modeling of lung tumors
Academic Activities: Organized LUCC - Lung Cancer Meetings in 2024 and presented at similar events in 2022. Her research contributes to UN Sustainable Development Goals in health and well-being.
۰مقاله منتشرشده
